News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
CSPC PHARMA Forges Strategic Research Collaboration Deal with AstraZeneca
CSPC PHARMA (01093.HK) announced that it had entered into a strategic research collaboration agreement with AstraZeneca for the discovery and development of novel oral small molecu...
Reset
Send
The window will close in 5 seconds
CSPC PHARMA Forges Strategic Research Collaboration Deal with AstraZeneca
Close
Recommend
9
Positive
11
Negative
2
 
 

CSPC PHARMA (01093.HK)  +0.350 (+4.046%)    Short selling $353.89M; Ratio 33.112%   announced that it had entered into a strategic research collaboration agreement with AstraZeneca for the discovery and development of novel oral small molecule candidates utilizing the group's AI-driven, dual-engine efficient drug discovery platform.

Under the terms of the agreement, CSPC PHARMA agreed to discover pre-clinical candidates (PCC) for multiple targets as selected by AstraZeneca with potential to treat diseases across indications, including a pre-clinical small molecule oral therapy for immunological diseases.

Related NewsCiti: 11th Batch of GPO Shows Official Support for Industry Innovation & Rational Competition; Price Cut Expected to be Mild
For each PCC program, AstraZeneca will have rights to exercise the option for an exclusive license for development, manufacturing and commercialization worldwide.

Meanwhile, CSPC PHARMA will receive an upfront payment of USD110 million, and is also eligible to receive up to USD1.62 billion in potential development milestone payments and up to USD3.6 billion in potential sales milestone payments, plus potential single digit royalties based on annual net sales of the products.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-17 12:25.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.